FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1775885739> ?p ?o ?g. }

• W1775885739 endingPage "1794" @default.
• W1775885739 startingPage "1786" @default.
• W1775885739 abstract "The cathepsin K inhibitor odanacatib (ODN), currently in phase 3 development for postmenopausal osteoporosis, has a novel mechanism of action that reduces bone resorption while maintaining bone formation. In phase 2 studies, odanacatib increased areal bone mineral density (aBMD) at the lumbar spine and total hip progressively over 5 years. To determine the effects of ODN on cortical and trabecular bone and estimate changes in bone strength, we conducted a randomized, double-blind, placebo-controlled trial, using both quantitative computed tomography (QCT) and high-resolution peripheral (HR-p)QCT. In previously published results, odanacatib was superior to placebo with respect to increases in trabecular volumetric BMD (vBMD) and estimated compressive strength at the spine, and integral and trabecular vBMD and estimated strength at the hip. Here, we report the results of HR-pQCT assessment. A total of 214 postmenopausal women (mean age 64.0 ± 6.8 years and baseline lumbar spine T-score –1.81 ± 0.83) were randomized to oral ODN 50 mg or placebo, weekly for 2 years. With ODN, significant increases from baseline in total vBMD occurred at the distal radius and tibia. Treatment differences from placebo were also significant (3.84% and 2.63% for radius and tibia, respectively). At both sites, significant differences from placebo were also found in trabecular vBMD, cortical vBMD, cortical thickness, cortical area, and strength (failure load) estimated using finite element analysis of HR-pQCT scans (treatment differences at radius and tibia = 2.64% and 2.66%). At the distal radius, odanacatib significantly improved trabecular thickness and bone volume/total volume (BV/TV) versus placebo. At a more proximal radial site, odanacatib attenuated the increase in cortical porosity found with placebo (treatment difference = –7.7%, p = 0.066). At the distal tibia, odanacatib significantly improved trabecular number, separation, and BV/TV versus placebo. Safety and tolerability were similar between treatment groups. In conclusion, odanacatib increased cortical and trabecular density, cortical thickness, aspects of trabecular microarchitecture, and estimated strength at the distal radius and distal tibia compared with placebo. © 2014 American Society for Bone and Mineral Research" @default.
• W1775885739 created "2016-06-24" @default.
• W1775885739 creator A5015046378 @default.
• W1775885739 creator A5022037416 @default.
• W1775885739 creator A5024548519 @default.
• W1775885739 creator A5032270670 @default.
• W1775885739 creator A5036528950 @default.
• W1775885739 creator A5039835673 @default.
• W1775885739 creator A5043462798 @default.
• W1775885739 creator A5063033406 @default.
• W1775885739 creator A5066206567 @default.
• W1775885739 creator A5077748517 @default.
• W1775885739 creator A5086425417 @default.
• W1775885739 creator A5091603719 @default.
• W1775885739 date "2014-07-21" @default.
• W1775885739 modified "2023-10-16" @default.
• W1775885739 title "Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength" @default.
• W1775885739 cites W1557542853 @default.
• W1775885739 cites W18924068 @default.
• W1775885739 cites W1963957178 @default.
• W1775885739 cites W1975535182 @default.
• W1775885739 cites W1976387068 @default.
• W1775885739 cites W1990076994 @default.
• W1775885739 cites W1990552515 @default.
• W1775885739 cites W1992001223 @default.
• W1775885739 cites W2000411736 @default.
• W1775885739 cites W2011901656 @default.
• W1775885739 cites W2014973716 @default.
• W1775885739 cites W2018515170 @default.
• W1775885739 cites W2020001995 @default.
• W1775885739 cites W2021542350 @default.
• W1775885739 cites W2029090208 @default.
• W1775885739 cites W2031881697 @default.
• W1775885739 cites W2033745075 @default.
• W1775885739 cites W2035204509 @default.
• W1775885739 cites W2057920291 @default.
• W1775885739 cites W2065305027 @default.
• W1775885739 cites W2088240061 @default.
• W1775885739 cites W2105510043 @default.
• W1775885739 cites W2109372280 @default.
• W1775885739 cites W2113264234 @default.
• W1775885739 cites W2113523811 @default.
• W1775885739 cites W2115028313 @default.
• W1775885739 cites W2139586263 @default.
• W1775885739 cites W2158387027 @default.
• W1775885739 cites W2167751454 @default.
• W1775885739 doi "https://doi.org/10.1002/jbmr.2194" @default.
• W1775885739 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24643905" @default.
• W1775885739 hasPublicationYear "2014" @default.
• W1775885739 type Work @default.
• W1775885739 sameAs 1775885739 @default.
• W1775885739 citedByCount "61" @default.
• W1775885739 countsByYear W17758857392014 @default.
• W1775885739 countsByYear W17758857392015 @default.
• W1775885739 countsByYear W17758857392016 @default.
• W1775885739 countsByYear W17758857392017 @default.
• W1775885739 countsByYear W17758857392018 @default.
• W1775885739 countsByYear W17758857392019 @default.
• W1775885739 countsByYear W17758857392020 @default.
• W1775885739 countsByYear W17758857392021 @default.
• W1775885739 countsByYear W17758857392022 @default.
• W1775885739 countsByYear W17758857392023 @default.
• W1775885739 crossrefType "journal-article" @default.
• W1775885739 hasAuthorship W1775885739A5015046378 @default.
• W1775885739 hasAuthorship W1775885739A5022037416 @default.
• W1775885739 hasAuthorship W1775885739A5024548519 @default.
• W1775885739 hasAuthorship W1775885739A5032270670 @default.
• W1775885739 hasAuthorship W1775885739A5036528950 @default.
• W1775885739 hasAuthorship W1775885739A5039835673 @default.
• W1775885739 hasAuthorship W1775885739A5043462798 @default.
• W1775885739 hasAuthorship W1775885739A5063033406 @default.
• W1775885739 hasAuthorship W1775885739A5066206567 @default.
• W1775885739 hasAuthorship W1775885739A5077748517 @default.
• W1775885739 hasAuthorship W1775885739A5086425417 @default.
• W1775885739 hasAuthorship W1775885739A5091603719 @default.
• W1775885739 hasBestOaLocation W17758857391 @default.
• W1775885739 hasConcept C101990758 @default.
• W1775885739 hasConcept C105702510 @default.
• W1775885739 hasConcept C126322002 @default.
• W1775885739 hasConcept C126894567 @default.
• W1775885739 hasConcept C142724271 @default.
• W1775885739 hasConcept C170493617 @default.
• W1775885739 hasConcept C204787440 @default.
• W1775885739 hasConcept C27081682 @default.
• W1775885739 hasConcept C2776033226 @default.
• W1775885739 hasConcept C2776541429 @default.
• W1775885739 hasConcept C2776886416 @default.
• W1775885739 hasConcept C2777236700 @default.
• W1775885739 hasConcept C2777425516 @default.
• W1775885739 hasConcept C2779329777 @default.
• W1775885739 hasConcept C2781451080 @default.
• W1775885739 hasConcept C71924100 @default.
• W1775885739 hasConceptScore W1775885739C101990758 @default.
• W1775885739 hasConceptScore W1775885739C105702510 @default.
• W1775885739 hasConceptScore W1775885739C126322002 @default.
• W1775885739 hasConceptScore W1775885739C126894567 @default.
• W1775885739 hasConceptScore W1775885739C142724271 @default.
• W1775885739 hasConceptScore W1775885739C170493617 @default.

• next